Solventum Corporation (SOLV) Operating Margin: 25.54%
Is Solventum Corporation’s operating margin high or low?
Solventum Corporation's operating margin of 25.54% is 25% above its 5-year average of 20.47%, near the high end of its 5-year range (12.55%–26.20%).
As of Friday, June 12, 2026. 31.82% above its 12-month average of 19.38%.
SOLV Operating Margin Chart
SOLV Average Operating Margin Chart
SOLV Current vs Average Operating Margin Chart
SOLV Operating Margin Metrics
OPERATING MARGIN
25.54%
OPERATING MARGIN AVG TTM
19.38%
OPERATING MARGIN AVG 3Y
20.05%
OPERATING MARGIN AVG 5Y
20.47%
OPERATING MARGIN AVG 10Y
20.47%
OPERATING MARGIN AVG 15Y
20.47%
OPERATING MARGIN AVG 20Y
20.47%
CURRENT VS TTM AVG
+31.82%
CURRENT VS 3Y AVG
+27.37%
CURRENT VS 5Y AVG
+24.74%
CURRENT VS 10Y AVG
+24.74%
CURRENT VS 15Y AVG
+24.74%
CURRENT VS 20Y AVG
+24.74%
SOLV Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 25.54% | 19.38% | 20.05% | 20.47% |
| Align Technology, Inc. (ALGN) | $12.27B | 14.44% | 15.23% | 16.08% | 17.45% |
| Baxter International Inc. (BAX) | $10.58B | -2.65% | -1.31% | -6.02% | 0.15% |
| Hologic, Inc. (HOLX) | $16.97B | 17.49% | 19.66% | 22.41% | 27.16% |
| Charles River Laboratories International, Inc. (CRL) | $8.94B | 11.77% | 9.13% | 12.39% | 13.51% |
| Moderna, Inc. (MRNA) | $18.71B | -153.35% | -140.72% | -73.36% | -52.24% |
| Tempus AI, Inc. (TEM) | $8.65B | -18.13% | -59.22% | -59.52% | -72.58% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.92B | 9.25% | 10.48% | 12.70% | 14.08% |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 1.32% | 4.35% | -1.93% | -10.04% |
| BioNTech SE (BNTX) | $22.39B | -51.55% | -35.20% | 5.18% | 14.03% |
Operating Efficiency
Gross Margin
53.7%
Operating Margin
25.5%
Solventum Corporation Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Operating Margin FAQ
- What is the operating margin for Solventum Corporation (SOLV)?
- The operating margin for SOLV stock is 25.54%.
- Is Solventum Corporation's operating margin high or low?
- Solventum Corporation's operating margin of 25.54% is 25% above its 5-year average of 20.47%, near the high end of its 5-year range (12.55%–26.20%).
- What is the TTM average operating margin for Solventum Corporation (SOLV)?
- The TTM average operating margin for SOLV stock is 19.38%.
- What is the 3Y average operating margin for Solventum Corporation (SOLV)?
- The 3Y average operating margin for SOLV stock is 20.05%.
- What is the 5Y average operating margin for Solventum Corporation (SOLV)?
- The 5Y average operating margin for SOLV stock is 20.47%.
- What is the 10Y average operating margin for Solventum Corporation (SOLV)?
- The 10Y average operating margin for SOLV stock is 20.47%.
- What is the 15Y average operating margin for Solventum Corporation (SOLV)?
- The 15Y average operating margin for SOLV stock is 20.47%.
- What is the 20Y average operating margin for Solventum Corporation (SOLV)?
- The 20Y average operating margin for SOLV stock is 20.47%.
Solventum Corporation Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 26.20% |
| 2024-12-31 | 12.55% |
| 2023-12-31 | 20.64% |
| 2022-12-31 | 20.82% |
| 2021-12-31 | 23.00% |
| 2020-12-31 | 19.64% |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson